5-methoxycarbonylmethyl-2-thiouridine structure
|
Common Name | 5-methoxycarbonylmethyl-2-thiouridine | ||
|---|---|---|---|---|
| CAS Number | 20299-15-4 | Molecular Weight | 332.33 | |
| Density | 1.6±0.1 g/cm3 | Boiling Point | N/A | |
| Molecular Formula | C12H16N2O7S | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of 5-methoxycarbonylmethyl-2-thiouridine5-Methoxycarbonylmethyl-2-thiouridine is a purine nucleoside analogue. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. |
| Name | 5-methoxycarbonylmethyl-2-thiouridine |
|---|---|
| Synonym | More Synonyms |
| Description | 5-Methoxycarbonylmethyl-2-thiouridine is a purine nucleoside analogue. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. |
|---|---|
| Related Catalog | |
| References |
| Density | 1.6±0.1 g/cm3 |
|---|---|
| Molecular Formula | C12H16N2O7S |
| Molecular Weight | 332.33 |
| Exact Mass | 332.067810 |
| LogP | -0.43 |
| Index of Refraction | 1.673 |
| 4(1H)-Pyrimidinone, 2,3-dihydro-5-(2-methoxy-2-oxoethyl)-1-β-D-ribofuranosyl-2-thioxo- |
| 5-methoxycarbonylmethyl-2-thiouridine |
| 5-(2-Methoxy-2-oxoethyl)-1-(β-D-ribofuranosyl)-2-thioxo-2,3-dihydro-4(1H)-pyrimidinone |